Concepedia

Andrew Douglas

AD

5

Publications

226

Citations

5

H-Index

2007

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Sidney Kimmel Cancer Center

University of Pennsylvania

Thomas Jefferson University

Andrew Douglas is an author at Bristol-Myers Squibb (United States) specializing in cell death, autophagy, and cell signaling.

Top concepts

Publications per year

2007–2021

5

Publications

5

Structure of M11L: A myxoma virus structural homolog of the apoptosis inhibitor, Bcl‐2

Andrew Douglas, Kevin D. Corbett, James M. Berger et al. · Protein Science · 2007 · 77 citations · Full text

, , +13

Smoothened Is a Fully Competent Activator of the Heterotrimeric G Protein Gi

Feng Shen, Lan Cheng, Andrew Douglas et al. · Molecular Pharmacology · 2013 · 74 citations · Full text

Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage

Amy C. Hart, Lynn M. Abell, Junqing Guo et al. · ACS Medicinal Chemistry Letters · 2019 · 34 citations · Full text

, , +22

A Selection of Macrocyclic Peptides That Bind STING From an mRNA‐Display Library With Split Degenerate Codons

Chi‐Wang Lin, Mary J. Harner, Andrew Douglas et al. · Angewandte Chemie International Edition · 2021 · 22 citations · Full text

The α Subunit of the G Protein G13 Regulates Activity of One or More Gli Transcription Factors Independently of Smoothened

Andrew Douglas, Jennifer Heim, Feng Shen et al. · Journal of Biological Chemistry · 2011 · 19 citations · Full text

Rows per page

1–5 of 5